Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of SAL003 in Combination With Statin Therapy in Patients With Hypercholesterolemia and Mixed Dyslipidemia [Phase 3]

View source ↗

Summary

A multicenter, randomized Phase III trial evaluated SAL003 in combination with statin therapy for hyperlipidemia and mixed dyslipidemia and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia
• Mixed Dyslipidemia

Drugs mentioned

• SAL003

Snippet

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. | Conditions: Hyperlipidemias, Hypercholesterolemia, Mixed Dyslipidemia | Phase 3 | Status: COMPLETED